Bcl-2 oncogene expression in estrogen receptor-positive and negative breast carcinoma.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Gynaecological Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19051812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of raloxifene on normal breast tissue from premenopausal women

  2005cited by this paper
• Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.

  2005cited by this paper
• Molecular evolution of breast cancer

  2005cited by this paper
• Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death

  2005cited by this paper
• Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

  2005cited by this paper
• Prognostic Value of Different Factors in Breast Carcinoma

  2004cited by this paper
• Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• Bcl‐2 expression on fine‐needle aspirates from primary breast carcinoma

  1999cited by this paper
• Clinical studies of apoptosis and proliferation in breast cancer.

  1999cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper
• Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.

  1997cited by this paper
• Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

  1996cited by this paper
• Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

  1995cited by this paper
• Prognostic value of bcl-2 expression in invasive breast cancer.

  1995cited by this paper
• Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen.

  1994cited by this paper
• Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

  1991cited by this paper

• The influence of morphology, follicle size and Bcl-2 and Bax transcripts on the developmental competence of bovine oocytes.

  2014cites this paper
• Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer

  2013cites this paper
• The current need to continue researching with embryonic stem cell

  2013cites this paper
• Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.

  2013cites this paper
• A necessidade atual em se continuar a pesquisar com células-tronco embrionárias

  2013cites this paper
• Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers.

  2013cites this paper
• The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women

  2012cites this paper
• Ki-67 and Bcl-2 in colorectal polyps with breast cancer.

  2011cites this paper
• MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

  2011cites this paper
• Evaluation of Ki‐67 and Bcl‐2 antigen expression in breast carcinomas of women treated with raloxifene

  2010cites this paper
• Ki-67 and Bcl-2 Antigen Expression in Adenomatous Colorectal Polyps from Women with Breast Cancer

  2010cites this paper
• E-cadherin expression in estrogen receptor-positive and negative breast carcinomas of postmenopausal women.

  2010cites this paper
• Immunohistochemical expression of E‐cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast

  2009cites this paper
• Analysis of Ki-67 and Bcl-2 protein expression in normal colorectal mucosa of women with breast cancer.

  2009cites this paper